Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-Jan-24 8:37 PM View:  | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 72,335 | -- | -- | (100%) 72.33K to 0 | |
| 10-Aug-23 4:22 PM View: | Mirati Therapeutics, Inc. (MRTX) | 09-Aug-23 | Grant | 22,297 | $37.00 | $824,989.00 | 45% 49.36K to 71.66K | |
| 02-Jul-20 4:35 PM View: | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 12,893 | $18.00 | $232,074.00 | (100%) 12.89K to 0 | |
| 03-Mar-20 6:58 PM View: | Portola Pharmaceuticals Inc (PTLA) | 02-Mar-20 | Payment of Exercise | 4,327 | $9.68 | $41,885.40 | (8%) 54.3K to 49.98K | |
| 04-Feb-20 7:03 PM View: | Portola Pharmaceuticals Inc (PTLA) | 03-Feb-20 | Payment of Exercise | 3,544 | $12.89 | $45,682.20 | (6%) 56.73K to 53.18K | |
| 04-Feb-20 7:03 PM View: | Portola Pharmaceuticals Inc (PTLA) | 31-Jan-20 | Grant | 16,250 | -- | -- | 40% 40.48K to 56.73K | |
| 05-Mar-19 6:30 PM View: | Portola Pharmaceuticals Inc (PTLA) | 04-Mar-19 | Payment of Exercise | 4,297 | $33.42 | $143,606.00 | (10%) 44.25K to 39.95K | < 1% |
| 04-Feb-19 5:56 PM View: | Portola Pharmaceuticals Inc (PTLA) | 31-Jan-19 | Grant | 18,750 | -- | -- | 75% 25.0K to 43.75K | |
| 30-Mar-18 5:24 PM View: | Portola Pharmaceuticals Inc (PTLA) | 29-Mar-18 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 08-Feb-18 7:16 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Feb-18 | Market Sale | 3,363 | $115.70 | $389,099.00 | (4%) 77.9K to 74.54K | (56%) |
| 08-Feb-18 7:16 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 06-Feb-18 | Grant | 27,989 | -- | -- | 56% 49.91K to 77.9K | |
| 07-Feb-18 6:35 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Feb-18 | Market Sale | 1,261 | $117.26 | $147,865.00 | (2%) 51.17K to 49.91K | (53%) |
| 01-Mar-17 7:46 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 01-Mar-17 | Market Sale | 282 | $132.50 | $37,365.00 | (< 1%) 44.95K to 44.67K | (36%) |
| 01-Mar-17 7:46 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-17 | Grant | 6,500 | -- | -- | 14% 45.58K to 52.08K | |
| 01-Mar-17 7:46 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-17 | Market Sale | 910 | $131.71 | $119,856.00 | (2%) 52.08K to 51.17K | (37%) |
| 01-Mar-17 7:46 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 27-Feb-17 | Market Sale | 612 | $131.20 | $80,294.40 | (1%) 46.48K to 45.86K | (37%) |
| 10-Feb-17 6:05 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 09-Feb-17 | Market Sale | 167 | $126.84 | $21,182.30 | (< 1%) 46.64K to 46.48K | (42%) |
| 08-Feb-17 4:40 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 07-Feb-17 | Market Sale | 135 | $128.09 | $17,292.20 | (< 1%) 46.78K to 46.64K | (40%) |
| 08-Feb-17 4:40 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 06-Feb-17 | Market Sale | 3,403 | $125.69 | $427,739.00 | (7%) 50.18K to 46.78K | (43%) |
| 13-Dec-16 6:24 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 12-Dec-16 | Market Sale | 1,044 | $118.61 | $123,829.00 | (2%) 51.23K to 50.18K | (52%) |
| 10-Aug-16 6:23 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Aug-16 | Market Sale | 135 | $137.14 | $18,513.90 | (< 1%) 51.36K to 51.23K | (31%) |
| 14-Jun-16 4:50 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 13-Jun-16 | Market Sale | 918 | $135.72 | $124,591.00 | (2%) 52.28K to 51.36K | (33%) |
| 01-Mar-16 6:32 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 29-Feb-16 | Market Sale | 1,201 | $138.91 | $166,833.00 | (2%) 53.48K to 52.28K | (30%) |
| 01-Mar-16 6:32 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 26-Feb-16 | Grant | 5,000 | -- | -- | 10% 48.48K to 53.48K | |
| 08-Feb-16 7:58 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Feb-16 | Market Sale | 2,633 | $138.09 | $363,578.00 | (5%) 51.13K to 48.5K | (30%) |
| 08-Feb-16 7:58 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Feb-16 | Market Sale | 1,969 | $143.45 | $282,447.00 | (4%) 53.1K to 51.13K | (25%) |
| 08-Feb-16 7:58 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 04-Feb-16 | Grant | 11,763 | -- | -- | 28% 41.34K to 53.1K | |
| 15-Dec-15 5:35 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 11-Dec-15 | Market Sale | 943 | $182.73 | $172,311.00 | (2%) 42.28K to 41.34K | 2% |
| 12-Feb-16 5:09 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 25-Nov-15 | Gift | 12 | -- | -- | (< 1%) 48.49K to 48.48K | |
| 12-Feb-16 5:09 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 18-Aug-15 | Gift | 10 | -- | -- | (< 1%) 48.5K to 48.49K | |
| 11-Aug-15 5:53 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 07-Aug-15 | Market Sale | 135 | $190.01 | $25,651.30 | (< 1%) 42.42K to 42.28K | 5% |
| 05-Aug-15 6:08 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Aug-15 | Option Exercise | 20,000 | $92.65 | $1,853,000.00 | 62% 32.43K to 52.43K | |
| 05-Aug-15 6:08 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Aug-15 | Market Option Sale | 10,010 | $198.44 | $1,986,380.00 | (19%) 52.43K to 42.42K | 9% |
| 12-Jun-15 6:26 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 11-Jun-15 | Market Sale | 914 | $170.00 | $155,380.00 | (3%) 33.34K to 32.43K | (6%) |
| 03-Mar-15 9:13 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 02-Mar-15 | Market Sale | 280 | $180.34 | $50,495.20 | (< 1%) 33.62K to 33.34K | < 1% |
| 03-Mar-15 9:13 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 27-Feb-15 | Grant | 6,845 | -- | -- | 26% 26.78K to 33.62K | |
| 12-Feb-15 9:07 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 10-Feb-15 | Market Sale | 1,490 | $171.15 | $255,013.00 | (5%) 28.27K to 26.78K | (5%) |
| 09-Feb-15 8:48 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 09-Feb-15 | Market Sale | 1,455 | $174.16 | $253,403.00 | (5%) 29.72K to 28.27K | (3%) |
| 09-Feb-15 8:48 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Feb-15 | Grant | 8,760 | -- | -- | 42% 20.96K to 29.72K | |
| 15-Dec-14 6:50 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 11-Dec-14 | Market Sale | 3,570 | $195.53 | $698,042.00 | (15%) 24.53K to 20.96K | 8% |
| 28-Oct-14 5:41 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 27-Oct-14 | Option Exercise | 10,000 | $92.65 | $926,500.00 | 41% 24.53K to 34.53K | |
| 28-Oct-14 5:41 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 27-Oct-14 | Market Option Sale (Planned) | 10,000 | $189.49 | $1,894,940.00 | (29%) 34.53K to 24.53K | 5% |
| 08-Oct-14 4:55 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 06-Oct-14 | Option Exercise | 10,000 | $95.65 | $956,500.00 | 41% 24.53K to 34.53K | |
| 08-Oct-14 4:55 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 06-Oct-14 | Market Option Sale (Planned) | 10,000 | $179.00 | $1,790,000.00 | (29%) 34.53K to 24.53K | (< 1%) |
| 04-Mar-14 5:36 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-14 | Grant | 2,300 | -- | -- | 10% 22.23K to 24.53K | |
| 10-Feb-14 6:46 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 07-Feb-14 | Market Sale | 1,036 | $155.60 | $161,198.00 | (4%) 23.27K to 22.23K | (16%) |
| 10-Feb-14 6:46 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 06-Feb-14 | Grant | 6,068 | -- | -- | 35% 17.2K to 23.27K | |
| 08-Feb-13 8:07 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 06-Feb-13 | Grant | 2,200 | -- | -- | 15% 15.0K to 17.2K | |
| 18-Dec-12 5:15 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 10-Dec-12 | Option Exercise | 15,000 | -- | -- | 100% 0 to 15.0K |